Considering that IL-17 could drive the tumor progression through TRAF-ERK5 pathways in cSCC (16), we hypothesized that DMBA could induce IL-17 production from keratinocytes to drive the proliferation of keratinocytes, leading to the development of cSCC. The gene discussed is IL17A; the disease is neoplasm.